Nebraska Cancer Specialists/Midwest Cancer Center - Legacy

Omaha, Nebraska 68130

3 studies enrolling now · 6 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Breast Cancer, Cancer Harboring BRAF Alterations, Cervical Cancer, Colon Cancer, Colorectal Cancer, Dyspareunia, Glioblastoma, HGG, LGG, Metastatic Colorectal Cancer, Metastatic Melanoma

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors — Recruiting now
• Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation — Completed
• HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma — Stopped early
• Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy — Completed